# Noopur Raje

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/noopur-raje/

## Facts

| Field | Value |
| --- | --- |
| Citations | 45,316 |
| Field | Multiple Myeloma Research and Treatments |
| h-index | 104 |
| i10-index | 379 |
| Last Known Institution | Massachusetts General Hospital |
| OpenAlex ID | https://openalex.org/A5052048627 |
| ORCID iD | https://orcid.org/0000-0003-3066-1275 |
| Works | 1,041 |

## Researcher papers

- [Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma](https://scholariq.org/papers/idecabtagene-vicleucel-in-relapsed-and-refractory-multiple-myeloma/)
- [Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma](https://scholariq.org/papers/anti-bcma-car-t-cell-therapy-bb2121-in-relapsed-or-refractory-multiple-myeloma/)
- [Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma](https://scholariq.org/papers/lenalidomide-bortezomib-and-dexamethasone-combination-therapy-in-patients-with/)
- [Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results](https://scholariq.org/papers/elranatamab-in-relapsed-or-refractory-multiple-myeloma-phase-2-magnetismm-3/)
- [Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma](https://scholariq.org/papers/triplet-therapy-transplantation-and-maintenance-until-progression-in-myeloma/)
- [Bortezomib induces canonical nuclear factor-κB activation in multiple myeloma cells](https://scholariq.org/papers/bortezomib-induces-canonical-nuclear-factor-b-activation-in-multiple-myeloma/)
- [A novel Aurora-A kinase inhibitor MLN8237 induces cytotoxicity and cell-cycle arrest in multiple myeloma](https://scholariq.org/papers/a-novel-aurora-a-kinase-inhibitor-mln8237-induces-cytotoxicity-and-cell-cycle/)
- [Ibrutinib Monotherapy in Symptomatic, Treatment-Naïve Patients With Waldenström Macroglobulinemia](https://scholariq.org/papers/ibrutinib-monotherapy-in-symptomatic-treatment-naive-patients-with-waldenstrom/)

## Researcher topics

- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)
- [Protein Degradation and Inhibitors](https://scholariq.org/topics/protein-degradation-and-inhibitors/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Peptidase Inhibition and Analysis](https://scholariq.org/topics/peptidase-inhibition-and-analysis/)
- [Bone health and treatments](https://scholariq.org/topics/bone-health-and-treatments/)

## Researcher university

- [Massachusetts General Hospital](https://scholariq.org/institutions/massachusetts-general-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.